Neuraminidase inhibitor
From Wikipedia, the free encyclopedia
Neuraminidase inhibitors are a class of antiviral drugs targeted at the influenza virus, which work by blocking the function of the viral neuraminidase protein, thus preventing the virus from reproducing by budding from the host cell.
Oseltamivir (Tamiflu) a prodrug, Zanamivir (Relenza), Laninamivir (Inavir), and Peramivir belong to this class. Unlike the M2 inhibitors, which work only against the influenza A, neuraminidase inhibitors act against both influenza A and influenza B.
Common side effects include nausea and vomiting.
Specific inhibitors
- Laninamivir
- Oseltamivir
- Zanamivir
- Peramivir
- Cyanidin-3-sambubioside (Extract of Sambucus nigra, black elderberry)[1]
See also
External resources
- This flash animation shows the mode of action of oseltamivir (Tamiflu)
- Replication of influenza virus
References
- ↑ Swaminathan K, Dyason JC, Maggioni A, von Itzstein M, Downard KM (2013). "Binding of a natural anthocyanin inhibitor to influenza neuraminidase by mass spectrometry". Anal Bioanal Chem. 405 (20): 6563–72. doi:10.1007/s00216-013-7068-x. PMID 23748498.
- ^ Gubareva LV (2004). "Molecular mechanisms of influenza virus resistance to neuraminidase inhibitors". Virus Research 103 (1–2): 199–203. doi:10.1016/j.virusres.2004.02.034. PMID 15163510.
| ||||||||||||||||||||||||||||
| |||||||||||||||||||
This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.